4 months ago
MASI
AnalystsVik ChopraVik Chopra's Stock Forecasts
AnalystsVik Chopra
Analyst Ranking
Top 44%
#2167 out of 4929 analysts
Average Return
+0.71%
Win Rate
39%7 out of 18
Risk vs Reward
Poor
Good
Vik Chopra's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alphatec Holdings IncATEC | +65.51% | $6.64 | $10.99 | 2024-07-31 - 2025-07-03 | Strong Buy |
Neuropace IncNPCE | +53.47% | $6.77 | $10.39 | 2024-08-13 - 2025-07-03 | Strong Buy |
Masimo CorpMASI | +20.21% | $139.43 | $167.61 | 2024-03-24 - 2025-03-24 | Strong Buy |
Nuvasive IncNUVA | +17.62% | $37.75 | $44.40 | 2022-11-09 - 2023-02-10 | Strong Buy |
Neuropace IncNPCE | +13.55% | $9.15 | $10.39 | 2024-11-12 - 2025-07-03 | Strong Buy |
Vik Chopra Analyst Color
Get additional color on Vik Chopra's coverage of popular stocks
Vik Chopra's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Masimo CorpMASI | 9 | Strong Buy | $190.00 | +13.39% | Maintains | 2 months ago |
Integra Lifesciences Holdings CorpIART | 2 | Hold | $13.00 | -3.63% | Maintains | 2 months ago |
Henry Schein IncHSIC | 2 | Hold | $75.00 | +0.44% | Maintains | 2 months ago |
Conmed CorpCNMD | 4 | Hold | $57.00 | +4.91% | Maintains | 2 months ago |
Align Technology IncALGN | 2 | Strong Buy | $246.00 | +24.99% | Maintains | 2 months ago |
Solventum CorpSOLV | 3 | Hold | $75.00 | -4.46% | Maintains | 4 months ago |
Dentsply Sirona IncXRAY | 2 | Hold | $19.00 | +13.98% | Maintains | 4 months ago |
Globus Medical IncGMED | 9 | Strong Buy | $93.00 | +57.17% | Maintains | 5 months ago |
Envista Holdings CorpNVST | 2 | Hold | $21.00 | +2.99% | Maintains | 5 months ago |
Neuropace IncNPCE | 2 | Strong Buy | $13.00 | +25.12% | Maintains | 8 months ago |
Alphatec Holdings IncATEC | 1 | Strong Buy | $19.00 | +72.88% | Maintains | a year ago |
Enovis CorpENOV | 3 | Strong Buy | $79.00 | N/A | Maintains | a year ago |
Nuvasive IncNUVA | 2 | Hold | $57.72 | N/A | Downgrades | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.